Latest papers

[Surgical treatment and outcome for postoperative recurrent or second primary lung cancer].

Late complications in blood and marrow transplant survivors.

[Therapeutic strategy for secondary lung cancer].

Surviving childhood cancer. Cure is not enough.

Summaries for patients. Cancer screening among adults who have survived childhood cancer.

[Iterative surgical resections for second primary and local recurrent lung cancer; comparison of lobectomy and limited resection].

[Surgical treatment for recurrent and second primary lung cancer].

[Surgical results for second primary lung cancer].

[Surgical treatment for recurrent pulmonary carcinoma including same and different cell types].

[Video-assisted thoracic surgery for metachronous lung cancer].

Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the childhood cancer survivor study.

Outcome of local failures after oral cancer - recurrence vs. second primary.

Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria.

Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone.

Predominant Brenner tumor combined with struma ovarii containing a papillary microcarcinoma associated with benign peritoneal strumosis: report of a case and histologic features.

Growth hormone therapy and the risk of tumor recurrence after brain tumor treatment in children.

Ghrelin-producing well-differentiated neuroendocrine tumor (carcinoid) of tailgut cyst. Morphological, immunohistochemical, ultrastructural, and RT-PCR study of a case and review of the literature.

Intrathoracic lymphadenopathy: sarcoidosis or metastatic seminoma? The diagnostic dilemma revisited.

Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.

[Oncological follow-up].